Trilipix patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7259186 ABBVIE Salts of fenofibric acid and pharmaceutical formulations thereof
Jan, 2025

(1 year, 3 months from now)

Trilipix is owned by Abbvie.

Trilipix contains Choline Fenofibrate.

Trilipix has a total of 1 drug patent out of which 0 drug patents have expired.

Trilipix was authorised for market use on 15 December, 2008.

Trilipix is available in capsule, delayed release;oral dosage forms.

The generics of Trilipix are possible to be released after 07 January, 2025.

Drugs and Companies using CHOLINE FENOFIBRATE ingredient

Market Authorisation Date: 15 December, 2008

Treatment: NA


How can I launch a generic of TRILIPIX before it's drug patent expiration?
More Information on Dosage

TRILIPIX family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic